Peter Michael Finan

Chief Executive Officer at Adorx Therapeutics Ltd.

Peter Michael Finan

Peter Michael Finan

Chief Executive Officer at Adorx Therapeutics Ltd.

Overview
Career Highlights

Adorx Therapeutics Ltd.

RelSci Relationships

402

Number of Boards

5

Birthday

1967

Age

53

Relationships
RelSci Relationships are individuals Peter Michael Finan likely has professional access to. A relationship does not necessarily indicate a personal connection.

Partner at Epidarex Capital Partners LLC

Relationship likelihood: Strong

Co-Founder & Managing Partner at Epidarex Capital Partners LLC

Relationship likelihood: Strong

Founder at MASA Life Science Ventures

Relationship likelihood: Strong

Managing Partner at Sixth Element Capital LLP

Relationship likelihood: Strong

Chief Executive Officer & Director at Enterprise Therapeutics Ltd.

Relationship likelihood: Strong

Venture Partner at Epidarex Capital Partners LLC

Relationship likelihood: Strong

Chief Executive Officer & Director at Epsilogen Ltd.

Relationship likelihood: Strong

Chief Executive Officer at Topas Therapeutics GmbH

Relationship likelihood: Strong

Professor at Dana-Farber Cancer Institute, Inc.

Relationship likelihood: Strong

Member, Adjunct Faculty at The Trudeau Institute

Relationship likelihood: Strong

In The News
The New York Times - Biographical Materials
March 3, 2013
Paid Notice: Deaths GARDE, HARRIET MERRITT DIXON
Paths to Peter Michael Finan
Potential Connections via
Relationship Science
You
Peter Michael Finan
Chief Executive Officer at Adorx Therapeutics Ltd.
Education

The University of Leeds (informally Leeds University, or simply Leeds) is a British Redbrick university located in the city of Leeds, West Yorkshire, England. Originally named the Yorkshire College of Science and later simply the Yorkshire College, it incorporated the Leeds School of Medicine and became part of the federal Victoria University alongside Owens College (which eventually became the University of Manchester) and University College Liverpool (which became the University of Liverpool). In 1904, a royal charter was granted to the University of Leeds by King Edward VII.

Career History
Venture Partner
2014 - Current

Epidarex Capital invests in companies located in the US and UK. The firm targets companies operating in the fields of health science including biotechnology, medical devices & pharmaceuticals, personalized medicine & diagnostics, healthcare IT and services. It provides financing for early stage capital requirements.

Chief Executive Officer
Current

Adorx Therapeutics Ltd. provides biotechnology, health care and therapeutics services. The company is headquartered in Edinburgh, the United Kingdom.

Head of Biology
Prior

Karus Therapeutics Ltd. provides therapies for treatment of cancer and inflammatory diseases. It offers HDAC6 and PI3K inhibitors for the treatment of cancer. The firm’s products in pipeline include KA-2237, KAR4000 Series and KAR3000 Series for the treatment of chronic inflammation, haematological malignancies, and solid tumours. The company was founded in July 2005 by Arasu Ganesan, Graham Keith Packham and Paul Townsend and is headquartered in Abingdon, the United Kingdom.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Peter Michael Finan. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Peter Michael Finan's profile does not indicate a business or promotional relationship of any kind between RelSci and Peter Michael Finan.